- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02239497
Femoral Preincisional Block in Acute Postoperative Pain Management of Surgery Orthopaedic Lower Limb
September 10, 2014 updated by: Beatriz Arismendi Gómez, Hospital Central Dr. Luis Ortega
Proper management of acute postoperative pain (DAPO) is essential for the recovery of orthopedic surgeries.
The blockade of the femoral nerve preincisional (BFP) is simple and its effectiveness increases guided by ultrasound and neurostimulation.
OBJECTIVE: To evaluate the effectiveness of BFP in patients undergoing orthopedic surgery of the lower limbs under general anesthesia.
METHODS: A comparative study was conducted, randomized, two groups, surgeries of the hip, femur and knee, ASA I-II, aged 18 years.
Group B (n = 15) received BFP and ultrasound-guided nerve stimulation with 20 ml of bupivacaine 0.5% plus epinephrine 1: 200,000.
Group S (n = 15) without blocking.
Both groups received intravenous analgesia with ketoprofen 100 mg regimen and dipyrone 1g c / 8 hs and balanced general anesthesia.
Postoperative morphine 0.03 mgr / kgr / weight was administered if EVA ≥4
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Estado Nueva Esparta
-
Porlamar, Estado Nueva Esparta, Venezuela, 6301
- Servicio de Anestesiologia Hospital "Dr. Luis Ortega"
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- ASA I and II patients, both sexes, plan for elective orthopaedic surgery of the lower limbs (femur and knee) under general anesthesia
Exclusion Criteria:
- Patients with any anesthetic or surgical complication
- Patients with neuromuscular diseases
- Allergy to any of the drugs used in the study
- Inability to understand and use a pain scale
- Also those patients in whom it was not possible to locate anatomical landmarks and / or failed femoral block
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: femoral block by US and NE and intravenous analgesia
preincisional femoral block by ultrasound and neurostimulation, with 20 ml bupivacaine 0,5% and epinephrine.
ketoprofen, dipyrone and dexamethasone IV.
Morphine IV to rescue analgesia
|
Intravenous analgesia with ketoprofen, dipyrone and dexamethasone.
IV morphine to rescue analgesia
|
|
Experimental: Intravenous analgesia
Intravenous analgesia with ketoprofen, dipyrone and morphine.
IV morphine to rescue analgesia
|
Intravenous analgesia with ketoprofen, dipyrone and dexamethasone.
IV morphine to rescue analgesia
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Postoperatory EVA values and need for rescue analgesia with IV morphine
Time Frame: 24 hours
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Beatriz S Arismendi Gomez, MD, Hospital "Dr Luis Ortega"
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Actual)
September 1, 2013
Study Registration Dates
First Submitted
September 7, 2014
First Submitted That Met QC Criteria
September 10, 2014
First Posted (Estimate)
September 12, 2014
Study Record Updates
Last Update Posted (Estimate)
September 12, 2014
Last Update Submitted That Met QC Criteria
September 10, 2014
Last Verified
September 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- Femoral Block
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.